Literature DB >> 31904765

Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy.

William G Mantyh1, Salvatore Spina1, Alex Lee1, Leonardo Iaccarino1, David Soleimani-Meigooni1, Elena Tsoy1, Taylor J Mellinger1, Harli Grant1, Lawren Vandevrede1, Renaud La Joie1, Orit Lesman-Segev1, Stephanie Gaus1, Katherine L Possin1, Lea T Grinberg1,2, Bruce L Miller1, William W Seeley1,2, Gil D Rabinovici1,3,4,5.   

Abstract

Importance: Biomarkers for chronic traumatic encephalopathy (CTE) are currently lacking. The radiotracer fluorine F 18-labeled (18F)-flortaucipir (FTP) detects tau pathology in Alzheimer disease, and positron emission tomography (PET) with FTP shows elevated binding in individuals at risk for CTE. No study, however, has assessed the correlation between in vivo FTP PET and postmortem tau in CTE. Objective: To assess the regional association between in vivo FTP binding and postmortem tau pathology in a patient with pathologically confirmed CTE. Design, Setting, and Participants: A white male former National Football League player with 17 years of US football exposure was clinically diagnosed with traumatic encephalopathy syndrome at a neurology tertiary referral center. 18F-Fludeoxyglucose, carbon 11-labeled Pittsburgh compound B, and FTP PET were performed 52 months prior to death, and magnetic resonance imaging, 50 months prior to death. Brain images were assessed qualitatively for abnormalities blinded to autopsy data. Autopsy was performed using a neurodegenerative research protocol. The FTP standardized uptake value ratios (inferior cerebellar gray reference region) and W-score (age-adjusted z-score) maps were compared with phosphorylated tau immunohistochemical analysis with monoclonal antibody CP13. Main Outcomes and Measures: Qualitative and quantitative comparisons between antemortem FTP PET and tau pathology at autopsy.
Results: Flortaucipir uptake was distributed in a patchy, frontotemporal-predominant pattern that overlapped with regions showing neurodegeneration on magnetic resonance imaging and hypometabolism on 18F-fludeoxyglucose PET. Pathological assessment revealed stage 4 CTE; limbic argyrophilic grain disease; stage 2 limbic-predominant, age-related transactive response DNA-binding protein 43 encephalopathy; and Braak neurofibrillary tangle stage 3. 18F-Flortaucipir W-maps matched areas of high postmortem tau burden in left fusiform and inferior temporal gyri and juxtacortical frontal white matter. High FTP W-scores with low tau burden were found in the basal ganglia, thalamus, motor cortex, and calcarine cortex. No regions with low FTP W-scores corresponded to areas with high pathological tau burden. A modest correlation, which did not reach statistical significance (ρ = 0.35, P = .17), was found between FTP standardized uptake value ratio and tau area fraction at the regional level. Conclusions and Relevance: In this patient, FTP PET findings during life showed a modest correspondence with postmortem pathology in CTE. These findings suggest that FTP may have limited utility as a tau biomarker in CTE.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31904765      PMCID: PMC6990867          DOI: 10.1001/jamaneurol.2019.4509

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  12 in total

1.  Tau Positron-Emission Tomography in Former National Football League Players.

Authors:  Robert A Stern; Charles H Adler; Kewei Chen; Michael Navitsky; Ji Luo; David W Dodick; Michael L Alosco; Yorghos Tripodis; Dhruman D Goradia; Brett Martin; Diego Mastroeni; Nathan G Fritts; Johnny Jarnagin; Michael D Devous; Mark A Mintun; Michael J Pontecorvo; Martha E Shenton; Eric M Reiman
Journal:  N Engl J Med       Date:  2019-04-10       Impact factor: 91.245

2.  Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology.

Authors:  Ruben Smith; Moa Wibom; Daria Pawlik; Elisabet Englund; Oskar Hansson
Journal:  JAMA Neurol       Date:  2019-03-01       Impact factor: 18.302

3.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

Authors:  Rik Ossenkoppele; Daniel R Schonhaut; Michael Schöll; Samuel N Lockhart; Nagehan Ayakta; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Andreas Lazaris; Averill Cantwell; Jacob Vogel; Miguel Santos; Zachary A Miller; Brianne M Bettcher; Keith A Vossel; Joel H Kramer; Maria L Gorno-Tempini; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Brain       Date:  2016-03-08       Impact factor: 13.501

4.  Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies.

Authors:  Salvatore Spina; Jesse A Brown; Jersey Deng; Raquel C Gardner; Alissa L Nana; Ji-Hye L Hwang; Stephanie E Gaus; Eric J Huang; Joel H Kramer; Howie J Rosen; John Kornak; John Neuhaus; Bruce L Miller; Lea T Grinberg; Adam L Boxer; William W Seeley
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

5.  Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span.

Authors:  Suzanne L Baker; Theresa M Harrison; Anne Maass; Renaud La Joie; William J Jagust
Journal:  J Nucl Med       Date:  2019-03-15       Impact factor: 10.057

6.  Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease.

Authors:  Joel H Kramer; Jennifer Jurik; Sharon J Sha; Kate P Rankin; Howard J Rosen; Julene K Johnson; Bruce L Miller
Journal:  Cogn Behav Neurol       Date:  2003-12       Impact factor: 1.600

7.  Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.

Authors:  Marta Marquié; Marc D Normandin; Charles R Vanderburg; Isabel M Costantino; Elizabeth A Bien; Lisa G Rycyna; William E Klunk; Chester A Mathis; Milos D Ikonomovic; Manik L Debnath; Neil Vasdev; Bradford C Dickerson; Stephen N Gomperts; John H Growdon; Keith A Johnson; Matthew P Frosch; Bradley T Hyman; Teresa Gómez-Isla
Journal:  Ann Neurol       Date:  2015-09-25       Impact factor: 10.422

Review 8.  Clinical subtypes of chronic traumatic encephalopathy: literature review and proposed research diagnostic criteria for traumatic encephalopathy syndrome.

Authors:  Philip H Montenigro; Christine M Baugh; Daniel H Daneshvar; Jesse Mez; Andrew E Budson; Rhoda Au; Douglas I Katz; Robert C Cantu; Robert A Stern
Journal:  Alzheimers Res Ther       Date:  2014-09-24       Impact factor: 6.982

9.  The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy.

Authors:  Ann C McKee; Nigel J Cairns; Dennis W Dickson; Rebecca D Folkerth; C Dirk Keene; Irene Litvan; Daniel P Perl; Thor D Stein; Jean-Paul Vonsattel; William Stewart; Yorghos Tripodis; John F Crary; Kevin F Bieniek; Kristen Dams-O'Connor; Victor E Alvarez; Wayne A Gordon
Journal:  Acta Neuropathol       Date:  2015-12-14       Impact factor: 17.088

10.  Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy.

Authors:  Orit H Lesman-Segev; Renaud La Joie; Melanie L Stephens; Ida Sonni; Richard Tsai; Viktoriya Bourakova; Adrienne V Visani; Lauren Edwards; James P O'Neil; Suzanne L Baker; Raquel C Gardner; Mustafa Janabi; Kiran Chaudhary; David C Perry; Joel H Kramer; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Neuroimage Clin       Date:  2019-10-17       Impact factor: 4.881

View more
  12 in total

1.  Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players.

Authors:  Michael L Alosco; Yi Su; Thor D Stein; Eric M Reiman; Ann C McKee; Robert A Stern; Hillary Protas; Jonathan D Cherry; Charles H Adler; Laura J Balcer; Charles Bernick; Surya Vamsi Pulukuri; Bobak Abdolmohammadi; Michael J Coleman; Joseph N Palmisano; Yorghos Tripodis; Jesse Mez; Gil D Rabinovici; Kenneth L Marek; Thomas G Beach; Keith A Johnson; Bertrand Russell Huber; Inga Koerte; Alexander P Lin; Sylvain Bouix; Jeffrey L Cummings; Martha E Shenton
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-24       Impact factor: 10.057

2.  The Legacy of the TTASAAN Report - Premature Conclusions and Forgotten Promises About SPECT Neuroimaging: A Review of Policy and Practice Part II.

Authors:  Dan G Pavel; Theodore A Henderson; Simon DeBruin; Philip F Cohen
Journal:  Front Neurol       Date:  2022-05-17       Impact factor: 4.086

3.  18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.

Authors:  David N Soleimani-Meigooni; Leonardo Iaccarino; Renaud La Joie; Suzanne Baker; Viktoriya Bourakova; Adam L Boxer; Lauren Edwards; Rana Eser; Maria-Luisa Gorno-Tempini; William J Jagust; Mustafa Janabi; Joel H Kramer; Orit H Lesman-Segev; Taylor Mellinger; Bruce L Miller; Julie Pham; Howard J Rosen; Salvatore Spina; William W Seeley; Amelia Strom; Lea T Grinberg; Gil D Rabinovici
Journal:  Brain       Date:  2020-12-05       Impact factor: 13.501

Review 4.  Neuroimaging Biomarkers of Chronic Traumatic Encephalopathy: Targets for the Academic Memory Disorders Clinic.

Authors:  Michael L Alosco; Julia Culhane; Jesse Mez
Journal:  Neurotherapeutics       Date:  2021-04-13       Impact factor: 7.620

Review 5.  Identifying degenerative effects of repetitive head trauma with neuroimaging: a clinically-oriented review.

Authors:  Breton M Asken; Gil D Rabinovici
Journal:  Acta Neuropathol Commun       Date:  2021-05-22       Impact factor: 7.801

Review 6.  Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease.

Authors:  Caitlin V M L Jie; Valerie Treyer; Roger Schibli; Linjing Mu
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-30

7.  Case Report: 18F-MK6240 Tau Positron Emission Tomography Pattern Resembling Chronic Traumatic Encephalopathy in a Retired Australian Rules Football Player.

Authors:  Natasha Krishnadas; Vincent Doré; Fiona Lamb; Colin Groot; Paul McCrory; Rodney Guzman; Rachel Mulligan; Kun Huang; Meaghan O'Donnell; Jennie Ponsford; Malcolm Hopwood; Victor L Villemagne; Christopher C Rowe
Journal:  Front Neurol       Date:  2020-12-22       Impact factor: 4.003

8.  Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project.

Authors:  Michael L Alosco; Megan L Mariani; Charles H Adler; Laura J Balcer; Charles Bernick; Rhoda Au; Sarah J Banks; William B Barr; Sylvain Bouix; Robert C Cantu; Michael J Coleman; David W Dodick; Lindsay A Farrer; Yonas E Geda; Douglas I Katz; Inga K Koerte; Neil W Kowall; Alexander P Lin; Daniel S Marcus; Kenneth L Marek; Michael D McClean; Ann C McKee; Jesse Mez; Joseph N Palmisano; Elaine R Peskind; Yorghos Tripodis; Robert W Turner; Jennifer V Wethe; Jeffrey L Cummings; Eric M Reiman; Martha E Shenton; Robert A Stern
Journal:  Alzheimers Res Ther       Date:  2021-08-12       Impact factor: 8.823

9.  Characterization of neuroinflammatory positron emission tomography biomarkers in chronic traumatic encephalopathy.

Authors:  Cassis Varlow; Ashley C Knight; Paul McQuade; Neil Vasdev
Journal:  Brain Commun       Date:  2022-02-03

10.  Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology.

Authors:  Adam Martersteck; Ivan Ayala; Daniel T Ohm; Callen Spencer; Christina Coventry; Sandra Weintraub; Eileen H Bigio; M -Marsel Mesulam; Changiz Geula; Emily Rogalski
Journal:  Acta Neuropathol Commun       Date:  2022-08-09       Impact factor: 7.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.